All Stories

  1. Regulation of Monocyte-Macrophage Responses in Cirrhosis—Role of Innate Immune Programming and Checkpoint Receptors

    Article • Frontiers in Immunology, February 2019, Frontiers

    Dr Antonio Riva

  2. Dynamin-1-like protein inhibition drives megamitochondria formation as an adaptive response in alcohol-induced hepatotoxicity

    Article • American Journal Of Pathology, December 2018, Elsevier

    Dr Antonio Riva

  3. Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B

    Article • Journal of Interferon & Cytokine Research, July 2018, Mary Ann Liebert Inc

    Dr Antonio Riva

  4. Immune checkpoint receptors: homeostatic regulators of immunity

    Article • Hepatology International, May 2018, Springer Science + Business Media

    Dr Antonio Riva

  5. Can we reliably predict response to corticosteroid treatment in severe alcoholic hepatitis?

    Article • Hepatology Communications, April 2018, Wiley

    Dr Antonio Riva

  6. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease

    Article • Gut, November 2017, BMJ

    Dr Antonio Riva, Dr Vishal C Patel

  7. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

    Article • Hepatology, October 2017, Wiley

    Dr Antonio Riva

  8. Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

    Article • Frontiers in Immunology, May 2017, Frontiers

    Dr Antonio Riva

  9. Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Riva

  10. Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

    Article • Critical Care Medicine, January 2016, Wolters Kluwer Health

    Dr Antonio Riva, Dr Vishal C Patel

  11. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Riva

  12. Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis

    Article • Gastroenterology, March 2015, Elsevier

    Dr Antonio Riva

  13. Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production

    Article • Gastroenterology, February 2015, Elsevier

    Dr Antonio Riva

  14. Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice

    Article • Gut, June 2014, BMJ

    Dr Antonio Riva

  15. Identification of Serum Cytokine Profiles Associated with HBeAg Seroconversion Following Antiviral Treatment Interruption

    Article • Viral Immunology, June 2014, Mary Ann Liebert Inc

    Dr Antonio Riva

  16. Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection

    Article • Hepatology, May 2014, Wolters Kluwer Health

    Dr Antonio Riva

  17. Association of Water Softness and Heavy Alcohol Consumption with Higher Hospital Admission Rates for Alcoholic Liver Disease

    Article • Alcohol and Alcoholism, September 2012, Oxford University Press (OUP)

    Dr Antonio Riva

  18. Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection

    Article • Journal of Viral Hepatitis, January 2012, Wiley

    Dr Antonio Riva

  19. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

    Article • Hepatology, October 2010, Wiley

    Dr Antonio Riva

  20. CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions

    Article • The Journal of Immunology, November 2009, The American Association of Immunologists

    Dr Antonio Riva

  21. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion

    Article • Hepatology, September 2008, Wiley

    Dr Antonio Riva

  22. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+T-cell proliferation in patients with hepatitis C virus infection

    Article • Immunology, June 2007, Wiley

    Dr Antonio Riva

  23. Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma

    Article • Clinical Immunology, June 2006, Elsevier

    Dr Antonio Riva

  24. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women

    Article • Journal of Hepatology, September 2005, Elsevier

    Dr Antonio Riva

  25. Peripheral blood dendritic cells increase in kidney-transplant patients without rejection

    Article • Clinical Immunology, February 2004, Elsevier

    Dr Antonio Riva

  26. Altered maturation of peripheral blood dendritic cells in patients with breast cancer

    Article • British Journal of Cancer, October 2003, Nature

    Dr Antonio Riva

  27. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon- 

    Article • Journal of Leukocyte Biology, October 2003, Society for Leukocyte Biology

    Dr Antonio Riva